In episode 47 we discuss the effectiveness of sublingual and injectable buprenorphine for patients with OUD, with and without fentanyl.
Nunes EV, Comer SD, Lofwall MR, Walsh SL, Peterson S, Tiberg F, Hjelmstrom P, Budilovsky-Kelley NR. Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use: A Post Hoc Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024 Jun 3;7(6):e2417377.
We also discuss the AMA’s Support of drug decriminalization, and the rise of alcohol-related health problems.
New York Times: Oregon Is Recriminalizing Drugs. Here’s What Portland Learned
Med Page Today: AMA’s House of Delegates Says Yes to Drug Decriminalization
Stat News: By the numbers: America’s alcohol-related health problems are rising fast
---
This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES.
---
Original theme music: composed and performed by Benjamin Kennedy
Audio Editing by Michael Bonanno
Executive Producer: Dr. Patrick Beeman
A podcast from Ars Longa Media
---
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group.
Email: addictionmedicinejournalclub@gmail.com
Facebook: @AddictionMedJC
Facebook Group: Addiction Medicine Journal Club
Instagram: @AddictionMedJC
Threads: @AddictionMedJC
Twitter/X: @AddictionMedJC
YouTube: addictionmedicinejournalclub
Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
Learn more about your ad choices. Visit megaphone.fm/adchoices
